Anti-CD22 (Inotuzumab)-hydrazone-Calicheamicin ADC
This ADC product is comprised of a Inotuzumab conjugated via a hydrazone linker to a Calicheamicin. The Calicheamicin is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, Calicheamicin binds to DNA, causes DNA damage.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1094417-01 0.02 mg (E-Coli)
Recombinant Wolbachia sp. subsp. Drosophila simulans tRNA modification GTPase MnmE (mnmE)
Sign In for Pricing
View Details 
MBS1094417-02 0.02 mg (Yeast)
Recombinant Wolbachia sp. subsp. Drosophila simulans tRNA modification GTPase MnmE (mnmE)
Sign In for Pricing
View Details